Symeres CZ passed commercial inspection

Posted on 5 January 2023

What started as a small investigation between client projects, over the years, has grown into a project of great significance. Our team at Symeres CZ developed a new process for the production of Penfluridol, a powerful antipsychotic used in the treatment of schizophrenia. In the past months, process validation was completed, culminating in a successful inspection by the Czech authorities, SUKL. With completing this important step, the path is clear for our client to obtain market authorization and deliver our high-quality product to patients over the course of this year. This is a major achievement by our team in Prague and an important milestone for Symeres.

Do you have a compound in drug development? Contact us to find out how we can help you!

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us